Immunotherapy and immunoescape in colorectal cancer

doi:10.3748/wjg.v13.i44.5822

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4518)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

402

HTML

3845

Figures (1-2)

150

Tables (1-1)

121

Sum=4518

Nov 28, 2007 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 28, 2007; 13(44): 5822-5831
Published online Nov 28, 2007. doi: 10.3748/wjg.v13.i44.5822

Full Size Figure Download Figure

Figure 2 Systemic treatment with agonist anti-CD137 monoclonal antibodies eradicates transplanted murine colon cancers. Mice subcu-taneously grafted with 5 x 10⁵ CT26 or MC38 cells were treated with anti-CD137 (2A) mAb or polyclonal rat IgG as a control. Sequential follow up of tumor size (mean diameter) is depicted for individual mice.

Citation: Mazzolini G, Murillo O, Atorrasagasti C, Dubrot J, Tirapu I, Rizzo M, Arina A, Alfaro C, Azpilicueta A, Berasain C, Perez-Gracia JL, Gonzalez A, Melero I. Immunotherapy and immunoescape in colorectal cancer. World J Gastroenterol 2007; 13(44): 5822-5831
URL: https://www.wjgnet.com/1007-9327/full/v13/i44/5822.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i44.5822